ABLE Trial Tests AKG for Aging Health Outcomes

S

Siim Land in his YouTube video 'The One Supplement to Rule Them All - NOVOS Core Review'

Quotes From Source

“Clinical trial called Able uses 1,000 mg of calcium AKG ...”

Story of claim

The ABLE clinical trial tests 1,000 mg of calcium AKG on 120 adults aged 40-60 for functional outcomes like grip strength over 6 months.

  • Goal: To evaluate calcium AKG's impact on aging-related health outcomes.
  • Proof: Trial aims to provide data on AKG's effects on functional health markers and aging.
  • Nuances:
    • Trial includes measures like aerobic capacity and arterial stiffness
    • 120 participants aged 40-60
  • Impact on Life: May reveal significant insights into aging interventions, affecting future health guidelines.

Investments

  • Price: Participation in trial, no additional cost
  • Time: 6-month trial period
  • Effort: Commitment to trial protocols and regular assessments

Risks

Standard clinical trial risks, including potential side effects from supplementation.

Alternatives

  • Other aging interventions such as lifestyle modifications

Get Started 🚀

  • Inquire about participation in clinical trials
  • Undergo initial health assessments
  • Follow trial guidelines and supplementation regimens

Brogevity AI can make mistakes. Check important info.

Reference Video